HYPR Hyperfine Inc

By Dean Seal

Shares of Hyperfine Inc. are down 25% to $2.01 in premarket trading after the company said its president and chief executive is stepping down for personal reasons.

The medical-devices company said after the bell Wednesday that Dave Scott will formally exit on July 29, and that he also plans to step down from Hyperfine's board.

Scott Huennekens, the company's executive chairman, will take over as interim president and CEO while Hyperfine conducts a search for Mr. Scott's permanent successor, it said.

The company said it wouldn't revise the full-year financial guidance it provided last month, which forecasts between $10 million and $20 million in annual revenue.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

June 30, 2022 07:18 ET (11:18 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.